Harvard gene Corp.

About Me

About Harvard Gene Corp.

Harvard Gene Corp. is a global enterprise dedicated to the research, development, production, sales, and service of high-quality nutritional supplements. Founded by Martin Capras, a renowned American molecular biologist and professor at Harvard Medical School, in 1972, Harvard Genomics was born from a profound exploration of human genetics and life sciences. As a leader in the field of health and nutrition, Harvard Genomics focuses on providing a range of scientifically innovative, natural, pure, and effective dietary supplements to consumers worldwide. Its products have covered more than 20 countries and regions including Europe, Asia, and North America, with annual global sales exceeding 3.2 billion US dollars.

 

With its excellent product quality, advanced technological research and development, and strong market insights, Harvard Gene Company has become one of the benchmark brands in the global field of biological science nutritional supplements.

 

Received FDA certification as the Food and Drug Administration of the United States; CGMP certification is provided by the US Food and Drug Administration; NSF stands for National Health Foundation in the United States; SGS is an internationally recognized testing, inspection, and certification organization; HACCP (Hazard Analysis and Critical Control Points); HALAL certification; Multiple authoritative certifications such as ISO (International Organization for Standardization).

Our History and Our Future

  • 1972: Brand establishment

    The origin of Harvard Gene Corp. can be traced back to 1972, when Professor Martin Kapilas revealed the mysteries of human genetics through molecular biology research at Harvard Medical School, making groundbreaking contributions to the advancement of global nutrition and health sciences. The professor's research findings inspired his idea of founding Harvard Genomics, which aims to combine genetic discoveries with advanced biotechnology to develop high-quality nutritional supplements based on science.
  • 1975: Construction of laboratories and production factories

    With the gradual development of the brand, Harvard Genomics established its first specialized laboratory in Long Island, New York in 1975, and subsequently built a standardized and intelligent production factory in Colorado, comprehensively improving its product research and development capabilities and production level.
  • 1978: The first batch of products were launched

    In 1978, Harvard Genomics launched its first batch of nutritional supplements and successfully launched them in California, USA. These products are based on the latest achievements in genetic research and biotechnology, helping consumers improve their health, enhance physical fitness, and resist aging, and have gained high recognition in the market.
  • 1979: Breakthrough biological purification technology

    In 1979, Harvard Gene Corp. successfully developed advanced biological purification technology, marking a significant breakthrough for the brand in the field of health technology. The application of this technology has enabled Harvard Genomics' products to reach industry-leading levels in quality, safety, and efficacy, laying a solid technological foundation for the global expansion of the brand.
  • 1980: Entered the European market

    In 1980, Harvard Gene Corp. first introduced its products to the European market and quickly gained widespread attention and praise. This move not only promotes the popularization of dietary supplements in Europe, but also triggers important discussions on health and nutrition worldwide.
  • 2000: Entered the Asian market

    In 2000, Harvard Gene Corp. officially entered the Asian market and achieved great success in the Asian market with advanced health concepts and technological capabilities. Harvard Genomics' products have been well received and become an important participant in the Asian nutritional supplement market by being customized to meet the specific needs of Asian consumers.
  • 2008: Leading position on the entire online network

    In 2008, Harvard Gene Corp., with its strong brand influence and excellent product quality, achieved a leading position in the industry on online e-commerce platforms in the European market, becoming one of the top 10 brands in the nutritional supplement category across the entire network.
  • 2022: Building a Big Health Ecosystem

    In 2022, Harvard Gene Corp. will work together with major research institutions and health industry companies to build a large health ecosystem, further expand the brand's health industry map, and strive to promote the sustainable development of global health through cross disciplinary cooperation.
  • 2024: Major Cooperation

    In 2024, Harvard Gene Corp. reached a significant cooperation agreement between China Resources Group and North American Pharmaceutical Co., Ltd., successfully signing an exclusive omnichannel distributor agreement in Asia. This milestone collaboration undoubtedly opens up a new chapter for Harvard Genomics' layout in the Asian market. With the advanced pharmaceutical concepts and technical support of North American Pharmaceutical Co., Ltd., Harvard Genomics is expected to rapidly expand its market share in Asia and provide high-quality gene related products and services to a wider range of regions in Asia. This collaboration is not accidental. In recent years, the demand for genetic technology related products and services in Asia has shown explosive growth, with enormous market potential. Harvard Genomics has keenly captured this market trend, and through its strong alliance with North American Pharmaceutical Co., Ltd., it can not only fully leverage the advantages of all parties and achieve optimized integration of resources, but also inject new vitality into the medical and health industry in Asia, promoting the popularization and application of genetic technology to new heights in the region.

Mission & Vision

Harvard Gene Corp. has always adhered to the core concept of "technology safeguards life" and is committed to promoting the development of global health through technological innovation. Its brand vision is "to protect life with technology, set a benchmark for human health, and become a pioneer brand in global bioscience nutrition supplementation". It strives to provide precise and effective nutritional support to every consumer worldwide through continuous optimization of product quality and service, helping them maintain health, delay aging, and enhance vitality.

The mission of the brand is to "professionally refine every step, strive for excellence in technical requirements, and provide high-quality services to every customer worldwide". Through continuous optimization of production processes and technology, we ensure that every product can meet the needs of consumers to the greatest extent possible.

Public welfare partners

Harvard Gene Corp. has established extensive partnerships with multiple international organizations, non-governmental organizations (NGOs), and global public health organizations to jointly promote the development of the health industry. These partners include:

  • United Nations Children's Fund (UNICEF)

    Harvard Gene Corp. and UNICEF have jointly launched a global children's nutrition improvement project, providing nutritional supplements to children around the world to help improve their growth and development.

  • World Food Programme (WFP)

    Through collaboration with the World Food Programme, Harvard Gene Corp. provides emergency nutritional assistance to residents in the world's poorest regions, particularly in Africa, South Asia, and Latin America

Featured Solutions

Learn about Harvard Gene Corp. portfolio of solutions to help address quality assurance, enhance regulatory predictability, and help manufacturers distribute quality medicines, dietary supplements and foods.